Search - tctmd.com

Displaying 81 - 100 of 245

Sort: Relevancy | Date

News Opinion CV Team Dispatch

April 2023 News Roundup

L.A. McKeown

April 01, 2023

News Opinion CV Team Dispatch

March 2023 News Roundup

L.A. McKeown

March 15, 2023

News Conference News ACC 2023

Multifaceted Approach to COORDINATE Diabetes Care Improves GDMT

Yael L. Maxwell

March 07, 2023

News Daily News

Cardiac Biomarkers May Help Refine HF Risk Stratification, Progression

L.A. McKeown

February 17, 2023

News Daily News

Food Insecurity May Drive Heart Failure, CAD Risks in Black Individuals

L.A. McKeown

February 06, 2023

News Daily News

AHA Annual Statistics Show COVID’s Disruptive Impact

L.A. McKeown

January 30, 2023

News Daily News

Semaglutide Effective for Weight Loss in Adolescents: STEP TEENS

Michael O'Riordan

December 30, 2022

News Daily News

ACC’s Valve Staging Tool Reveals Silent Disease is Common in the Elderly

L.A. McKeown

December 22, 2022

News Daily News

CVD Claimed 20 Million Lives in 2021, but Disease Burden Varies Globally

Michael O'Riordan

December 14, 2022

News Daily News

Analysis Cements Benefits of SGLT2 Inhibitors in HF, but Diabetes Matters for Deaths

Michael O'Riordan

December 08, 2022

News Daily News

Large Review Plumbs Possibilities, Pointlessness of Antioxidant Supplements

Michael O'Riordan

December 07, 2022

News Daily News

A Simple Nudge Moves the Needle on Statin Prescribing

Michael O'Riordan

December 02, 2022

News Daily News

Many ESC Guideline Recommendations Out of Reach in Poorer Regions

Michael O'Riordan

November 29, 2022

News Daily News

Sky-high Cost of SGLT2i and GLP1 Agonists Deter First-line Use

L.A. McKeown

October 05, 2022

News Daily News

Exercise Keeps Athletic Heart Supple, Strong, Healthy: JACC Deep Dive

Michael O'Riordan

September 09, 2022

News Conference News ESC 2022

DANCAVAS: Food for Thought as CV Screening in Older Men Misses Mark

L.A. McKeown

August 30, 2022

News Opinion Editor's Corner ESC 2022

What’s Going to Be Hot at ESC 2022?

Shelley Wood

August 22, 2022

News Daily News

Lowering BP Boosts CV Health Irrespective of Diabetes: Meta-analysis

Todd Neale

August 02, 2022

News Daily News

CV Risk Factors, Disease Projected to Explode in Coming Decades

L.A. McKeown

August 01, 2022

News Daily News

Dapagliflozin Safe, Effective in Diabetes Regardless of Background CV Meds

Shelley Wood

July 25, 2022

Advertisement

April 2023 News Roundup

March 2023 News Roundup

Multifaceted Approach to COORDINATE Diabetes Care Improves GDMT

Cardiac Biomarkers May Help Refine HF Risk Stratification, Progression

Food Insecurity May Drive Heart Failure, CAD Risks in Black Individuals

AHA Annual Statistics Show COVID’s Disruptive Impact

Semaglutide Effective for Weight Loss in Adolescents: STEP TEENS

ACC’s Valve Staging Tool Reveals Silent Disease is Common in the Elderly

CVD Claimed 20 Million Lives in 2021, but Disease Burden Varies Globally

Analysis Cements Benefits of SGLT2 Inhibitors in HF, but Diabetes Matters for Deaths

Large Review Plumbs Possibilities, Pointlessness of Antioxidant Supplements

A Simple Nudge Moves the Needle on Statin Prescribing

Many ESC Guideline Recommendations Out of Reach in Poorer Regions

Sky-high Cost of SGLT2i and GLP1 Agonists Deter First-line Use

Exercise Keeps Athletic Heart Supple, Strong, Healthy: JACC Deep Dive

DANCAVAS: Food for Thought as CV Screening in Older Men Misses Mark

What’s Going to Be Hot at ESC 2022?

Lowering BP Boosts CV Health Irrespective of Diabetes: Meta-analysis

CV Risk Factors, Disease Projected to Explode in Coming Decades

Dapagliflozin Safe, Effective in Diabetes Regardless of Background CV Meds

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content